BiomX Inc.

AMEX:PHGE

0.41 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q1
Revenue -2.017-0.088-0.087-0.089-0.09-0.091-0.134-0.05200000000000000000
Cost of Revenue 0.3310.2290.2120.2190.2170.2230.6240.6290.6350.6320.8190.6250.5660.555000000.6190.4050.0930.01600
Gross Profit -2.348-0.317-0.299-0.308-0.307-0.314-0.758-0.681-0.635-0.632-0.819-0.625-0.566-0.55500000-0.619-0.405-0.093-0.01600
Gross Profit Ratio 1.1643.6023.4373.4613.4113.4515.65713.09600000000000000000
Reseach & Development Expenses 6.8974.1052.6755.6413.8184.5643.1953.5364.5844.9296.5746.6083.8245.7946.4946.4364.0973.90813.489000000
General & Administrative Expenses 2.8282.682.5972.1542.2551.6441.9852.6332.3612.4772.8312.8453.0982.4972.5742.3942.2972.0588.71800.001000.0010
Selling & Marketing Expenses -0.331-0.229-0.212000000000000000000.2940000
SG&A 2.4972.4512.3852.1542.2551.6441.9852.6332.3612.4772.8312.8453.0982.4972.5742.3942.2972.0588.7180.6190.2950.0930.0160.0010.001
Other Expenses 2.0170.0880.0870.0890.090.0910.380.3800.380.380.380.380.37900000000000
Operating Expenses 9.3946.5565.067.7956.0736.2085.566.5497.3247.7869.7859.8337.3028.679.0688.836.3945.96622.2070.6190.2950.0930.0160.0010.001
Operating Income -9.725-6.785-5.272-0.382-6.073-6.208-5.56-6.549-7.324-7.786-61.1399.833-7.302-8.67-51.4488.83-6.394-5.966-18.919-0.619-0.295-0.093-0.016-0.001-0.001
Operating Income Ratio 4.82277.10260.5984.29267.47868.2241.493125.94200000000000000000
Total Other Income Expenses Net 14.201-10.537-0.2180.0890.09-0.147-0.287-0.223-0.149-0.37450.733-19.854-0.0310.27142.304-17.6650.1880.065-1.6440.375-0.0090.024-0.02100
Income Before Tax 4.476-17.322-5.49-0.382-6.403-6.355-5.847-6.772-7.473-8.16-10.406-10.021-7.333-8.399-9.144-8.835-6.206-5.901-20.563-0.2440.1150.350.019-0.001-0.001
Income Before Tax Ratio -2.219196.84163.1034.29271.14469.83543.634130.23100000000000000000
Income Tax Expense 0.0050.0050.0010.0080.0080.0060.0390.0080.0090.0090.051-0.010.0030.0030.0760.005-0.188-0.0651.6440.0480.0580.0690.00800
Net Income 4.471-17.327-5.491-0.382-6.411-6.361-5.886-6.78-7.482-8.169-10.457-10.011-7.336-8.402-9.144-8.835-6.206-5.901-22.207-0.2920.0570.2810.01-0.001-0.001
Net Income Ratio -2.217196.89863.1154.29271.23369.90143.925130.38500000000000000000
EPS 0.64-0.28-0.12-0.006-0.12-0.2-0.2-0.23-0.25-0.27-0.39-0.37-0.3-0.35-0.39-0.38-0.27-0.26-3.95-0.130.0250.130.006-0-0.001
EPS Diluted 0.64-0.28-0.12-0.006-0.12-0.2-0.2-0.23-0.25-0.27-0.39-0.37-0.3-0.35-0.39-0.38-0.27-0.26-3.95-0.130.0250.130.006-0-0.001
EBITDA -9.394-6.556-5.06-0.382-5.658-5.79-4.658-5.588-6.35-7.067-8.964-9.208-6.736-8.115-8.506-8.228-5.879-5.465-18.601-0.619-0.286-0.1170.005-0.001-0.001
EBITDA Ratio 4.65774.558.1614.29262.86763.62634.761107.46200000000000000000